Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma



Status:Archived
Conditions:Lymphoma
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:April 2009

Use our guide to learn which trials are right for you!

A Phase I Study of Intratumoral Poly-ICLC Plus Low Dose Local Radiation in Low Grade Recurrent B and T Cell Lymphoma


The primary objective of this study is to evaluate the safety of intratumoral
Polyinosinicpolycytidylic acid stabilized with polylysine and carboxymethylcellulose
(poly-ICLC)(Hiltonol®) in addition to low-dose local radiotherapy for adult patients with
low grade lymphomas, including follicular lymphoma, marginal zone lymphoma, small
lymphocytic lymphoma, chronic lymphocytic leukemia, and cutaneous T-cell lymphoma. The
secondary endpoints are response rate, immune responses, and durability of responses as well
as generation of antiinflammatory response at sites of tumor involvement.



We found this trial at
1
site
Las Vegas, Nevada 89135
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials